Cargando…
Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
A subgroup of patients with systemic sclerosis (SSc) develop interstitial lung disease (ILD), characterized by inflammation and progressive scarring of the lungs that can lead to respiratory failure. Although ILD remains the major cause of death in these individuals, there is no consensus statement...
Autores principales: | Mirsaeidi, Mehdi, Barletta, Pamela, Glassberg, Marilyn K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834642/ https://www.ncbi.nlm.nih.gov/pubmed/31737640 http://dx.doi.org/10.3389/fmed.2019.00248 |
Ejemplares similares
-
Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
por: Korsten, Peter, et al.
Publicado: (2021) -
Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
por: Kamenova, Antoniya, et al.
Publicado: (2023) -
Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease
por: Panagopoulos, Panagiotis K., et al.
Publicado: (2022) -
Sex and gender in interstitial lung diseases
por: Kawano-Dourado, Leticia, et al.
Publicado: (2021) -
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France
por: Cottin, Vincent, et al.
Publicado: (2021)